APOLLO HOSPITALS ENTER. L vs VIVIMED LABS LIMITED

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and VIVIMED LABS LIMITED (VIVIMEDLAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, APOLLO HOSPITALS ENTER. L leads APOLLOHOSP vs VIVIMEDLAB on 9 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability31
  • Growth10
  • Size & financial health31

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

64.66
P/E ratio
-1.30
12.55
P/B ratio
-0.52
0.23%
Dividend yield
0.00%
₹135.04
EPS
₹-3.85

Profitability

APOLLOHOSP takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
90.88%
18.00%
Return on capital
-8.00%
15.00%
EBITDA margin
-11.00%
7.94%
Net margin
-27.59%

Growth

APOLLOHOSP takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
-22.27%
33.39%
Profit CAGR (3Y) even

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.26L Cr
Market cap
₹57 Cr
₹25,228 Cr
Revenue
₹116 Cr
₹2,003 Cr
Net profit
₹-32 Cr
0.32
Debt / equity
0.00
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 76.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
VIVIMED LABS LIMITED
  • ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of -39.5% over past five years.", "Promoter holding is low: 7.57%", "Contingent liabilities of Rs.183 Cr.", "Company has high debtors of 236 days.", "Promoter holding has decreased over last 3 years: -13.4%"]
APOLLO HOSPITALS ENTER. L full analysis VIVIMED LABS LIMITED full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.